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Structure of unliganded HIV-1 reverse transcriptase at 2.7 Å
resolution: implications of conformational changes for
polymerization and inhibition mechanisms
Y Hsiou1, J Ding1, K Das1, AD Clark, Jr1, SH Hughes2 and E Arnold1*
Background:  HIV-1 reverse transcriptase (RT) is a major target for anti-HIV
drugs. A considerable amount of information about the structure of RT is
available, both unliganded and in complex with template-primer or non-
nucleoside RT inhibitors (NNRTIs). But significant conformational differences in
the p66 polymerase domain among the unliganded structures have complicated
the interpretation of these data, leading to different proposals for the
mechanisms of polymerization and inhibition.
Results:  We report the structure of an unliganded RT at 2.7 Å resolution,
crystallized in space group C2 with a crystal packing similar to that of the
RT–NNRTI complexes. The p66 thumb subdomain is folded into the DNA-
binding cleft. Comparison of the unliganded RT structures with the DNA-bound
RT and the NNRTI-bound RT structures reveals that the p66 thumb subdomain
can exhibit two different upright conformations. In the DNA-bound RT, the p66
thumb subdomain adopts an upright position that can be described as resulting
from a rigid-body rotation of the p66 thumb along the ‘thumb’s knuckle’ located
near residues Trp239 (in strand b14) and Val317 (in b15) compared with the
thumb position in the unliganded RT structure. NNRTI binding induces an
additional hinge movement of the p66 thumb near the thumb’s knuckle, causing
the p66 thumb to adopt a configuration that is even more extended than in the
DNA-bound RT structure.
Conclusions:  The p66 thumb subdomain is extremely flexible. NNRTI binding
induces both short-range and long-range structural distortions in several
domains of RT, which are expected to alter the position and conformation of the
template-primer. These changes may account for the inhibition of polymerization
and the alteration of the cleavage specificity of RNase H by NNRTI binding.
Introduction
The reverse transcriptase (RT) of human immunodefi-
ciency virus type 1 (HIV-1) is an attractive target for
antiviral drugs (see recent reviews in [1–4]). HIV-1 RT is a
heterodimer that consists of a 66 kDa subunit (p66) and 
a 51 kDa subunit (p51) (Fig. 1). The p66 subunit is com-
posed of a polymerase domain and an RNase H domain.
The p51 subunit contains only the polymerase domain.
Both the p66 and p51 polymerase domains contain four
subdomains (fingers, palm, thumb and connection)  which
are arranged differently in the two subunits. Only the p66
polymerase domain has a DNA-binding cleft, a functional
polymerase active site, and a site for binding non-nucleo-
side inhibitors (NNRTIs).
Structures of HIV-1 RT in complexes with various non-
nucleoside RT inhibitors (NNRTIs) [5–10], and in
complex with a 19-mer/18-mer double-stranded DNA and
an antibody Fab fragment [11] have been reported. Struc-
tures of unliganded HIV-1 RT have been solved in three
different crystal forms ([12,13], EA and coworkers, unpub-
lished data). It is reasonable to expect that comparing the
structures of unliganded HIV-1 RT with those of HIV-1
RT complexed with NNRTIs or nucleic acid should yield
valuable insights into the mechanisms of polymerization
and inhibition. This information should be useful in the
development of new or improved inhibitors of HIV-1 RT.
However, in the unliganded HIV-1 RT structures already
reported, there are significant conformational differences
in the p66 polymerase domain, particularly in the confor-
mation of the b6–b10–b9 sheet and the position of the p66
thumb subdomain ([12,13], EA and coworkers, unpub-
lished data). This has led to controversy regarding the role
of the p66 thumb in the polymerization reaction, and dif-
ferent interpretations of the inhibition mechanism of
HIV-1 RT by NNRTIs.
Here, we report the structure of an unliganded HIV-1 RT
crystallized in space group C2, a crystal form closely
related to, but not isomorphous with, that of a number of
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HIV-1 RT–NNRTI complexes reported previously. This
unliganded HIV-1 RT structure has a molecular packing
in the crystal lattice similar to that of the NNRTI-bound
HIV-1 RT structures crystallized in the C2 crystal form.
Comparison of these HIV-1 RT structures should there-
fore help to distinguish conformational changes induced
by NNRTI binding from changes caused by a different
crystal packing arrangement.
Results and discussion
Overview of HIV-1 RT structure and flexibility
Although the unliganded HIV-1 RT structure reported
here was determined in a crystal form similar to that
present in crystals of the HIV-1 RT–NNRTI complexes,
the cell parameters differ considerably. The unit cell of the
unliganded RT crystals is approximately 4% (10 Å) longer
along the a axis and 10% (10 Å) shorter along the c axis rel-
ative to that of the NNRTI-bound RT. This suggests that
the repositioning of the p66 thumb (see later discussion)
causes a considerable change in crystal packing. In the
structures of RT–NNRTI complexes with the C2 crystal
form, two symmetry-related molecules juxtapose in such a
way that the p66 fingers subdomain of one molecule con-
tacts both the RNase H domain and the tip of the p66
thumb subdomain of the other. In the crystal lattice of the
unliganded RT reported here, the RT molecules are
arranged in a manner similar to that in the RT–NNRTI
crystals. Even though the p66 thumb subdomain is folded
into the DNA-binding cleft, the same regions of the p66
thumb subdomain and the fingers subdomain of the sym-
metry-related molecule interact with each other, although
with different specific contacts. Compared with the rela-
tive positions of symmetry-related molecules in the
RT–NNRTI structures, the symmetry-related molecules
in this unliganded RT structure have a 20 Å translation in
the xz plane relative to each other. This translation permits
the RT molecules in this structure to pack more closely
along the c axis, and to expand slightly along the a axis,
which would account for the changes in the observed cell
parameters.
The structure of unliganded HIV-1 RT has been deter-
mined in several crystal forms. Rodgers et al. [12] reported
the structure of an unliganded HIV-1 RT in the space
group C2 with 4 molecules per asymmetric unit. We have
solved the structure of an unliganded HIV-1 RT com-
plexed with an antibody Fab fragment, which was crystal-
lized in space group P3212 with unit cell dimensions
isomorphous with those of the RT–DNA–Fab complex
(EA and coworkers, unpublished data). In these unli-
ganded HIV-1 RT structures, the p66 thumb subdomain
is folded down into the DNA-binding cleft. In the struc-
ture of unliganded RT reported here, the p66 thumb sub-
domain is also folded down into the DNA-binding cleft.
Therefore, with dramatically different crystal packing
arrangements, the RT molecules in these crystal lattices
exhibits strikingly similar folding. The rms deviations
between the structures of RT reported here and by
Rodgers et al. are 1.17 Å, 1.13 Å, and 0.97 Å based on the
superposition of Ca atoms for the whole RT molecule
(925 Ca atoms), the p66 subunit (475 Ca atoms), and the
p51 subunit (393 Ca atoms), respectively. The largest dif-
ference between subdomains is that the p66 thumb sub-
domain in the unliganded RT structure reported here is
rotated further into the DNA-binding cleft by 7° relative
to the structure reported by Rodgers et al. This displace-
ment could be the result of a relatively closer crystal
packing arrangement in the current crystal form. Esnouf et
al. [13] also described the structure of an unliganded HIV-
1 RT that was crystallized in space group P212121. In this
structure, the p66 thumb subdomain is in an upright
conformation similar to that seen in the structures of
RT–NNRTI complexes and the RT–DNA complex.
Moreover, the b6–b10–b9 sheet of the p66 palm sub-
domain moves toward the p66 thumb subdomain in a
manner different from that seen in the other unliganded
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Figure 1
Stereo Ca trace of the unliganded HIV-1 RT,
drawn using the program RIBBONS [32]. The
heterodimer is colored by subdomains:
fingers, blue; palm, red; thumb, green;
connection, yellow; and RNase H, orange.
Every 50th residue is labeled: p66, 1–556
and p51, 1001–1427.
RT structures ([12], EA and coworkers, unpublished
data). In the structure of unliganded HIV-1 RT reported
here, the position and conformation of the b6–b10–b9
sheet agree very well with that found in the unliganded
RT structures reported earlier ([12], EA and coworkers,
unpublished data).
The different conformation of the p66 thumb subdomain
and the repositioning of the b6–b10–b9 sheet in the unli-
ganded RT reported by Esnouf et al. [13] may be a conse-
quence of the method they used to prepare the unliganded
HIV-1 RT crystals. In that study, crystals were obtained by
soaking out a weakly-bound NNRTI inhibitor (HEPT)
from crystals of the HIV-1 RT–HEPT complex [13].
Examination of the molecular packing in the structure of
unliganded HIV-1 RT reported by Esnouf et al. indicates
that the p66 thumb subdomain is interlocked between the
p66 thumb and RNase H subdomains of the symmetry-
related RT molecule. It appears that the p66 thumb sub-
domain in this structure of unliganded RT is restricted by
crystal packing in such a way that it cannot fold down into
the DNA-binding cleft despite the NNRTI HEPT having
been soaked out. At any rate, the differences in the posi-
tion of the p66 thumb subdomain in different HIV-1 RT
structures provides ample evidence for high flexibility of
the p66 thumb subdomain; a flexibility that may play a
vital role in the binding and translocation of the nucleic
acid substrate.
Polymerase active site and NNRTI-binding pocket (NNIBP)
The polymerase active site is located at the b6–b10–b9
sheet of the p66 palm subdomain. The position of the
b9–b10 hairpin turn in the unliganded form is nearly iden-
tical to that in the NNRTI-bound HIV-1 RT, suggesting
that the position of the b6–b10–b9 sheet is not signifi-
cantly affected by the binding of an NNRTI. The
Tyr–Met–Asp–Asp motif (residues 183–186) in both the
p66 and p51 subunits is in an unusual bII′ turn conforma-
tion that has been observed in several other HIV-1 RT
structures [7–10,12,13]. Clear density peaks were found to
have good coordination geometry with Od1 of Asp185
(2.8 Å) and Od1 of Asp186 (2.8 Å) at the p66 polymerase
active site, and with the Od1 of Asp443 (3.1 Å), the Oε2 of
Glu478 (2.4 Å), and the Od1 and Od2 of Asp498 (2.5 Å and
2.4 Å, respectively), at the RNase H active site. Due to the
current resolution limit, we cannot distinguish whether
these peaks correspond to water or magnesium ions. Struc-
tures of the Moloney leukemia virus (MMLV) RT frag-
ment [14] and the fingers and palm subdomains of the p66
subunit in this unliganded HIV-1 RT (rms deviation of
1.4 Å based on 57 Ca atoms in the fingers and 56 Ca
atoms of the palm subdomain) were superposed. The
results indicate that the position of the electron density
peak at the polymerase active site in this unliganded
HIV-1 RT is quite close to that of the Mn2+ ion seen in the
MMLV RT structure.
The structures of RT complexed with the NNRTIs show
that the NNIBP is formed primarily by amino-acid
residues of the b5–b6 loop, b6, the b9–b10 hairpin, the
b12–b13 hairpin, and b15 of p66, and the b7–b8 connect-
ing loop of p51 [8]. In the structure of the unliganded RT
reported here and that reported by Rodgers et al., and in
the structure of the RT–DNA–Fab complex, the region
corresponding to the NNIBP in the RT–NNRTI struc-
tures is occupied by the side chains of Tyr181, Tyr188,
Phe227, and Trp229. When an NNRTI binds, the NNIBP
is created by the reorientation of the side chains of Tyr181
and Tyr188, and by the repositioning of the b12–b13–b14
sheet that contains the ‘primer grip’. In the unliganded
RT structure reported by Esnouf et al., a small cavity is
present at the NNIBP region and the b6–b10–b9 and
b12–b13–b14 sheets (using our nomenclature for sec-
ondary structural elements [11]) are shifted, along with the
side chains of residues Tyr181, Tyr183, and Tyr188,
toward this small residual cavity [13]. This reorientation of
the side chain of residue Tyr183 has not been seen in
other unliganded RTs ([12], EA and coworkers, unpub-
lished data). Because the p66 thumb subdomain in the
Esnouf et al. structure is apparently constrained in a con-
formation similar to that in the RT–NNRTI complex, the
displacement of the side chain of Tyr183 and the altered
positions of the b6–b10–b9 and b12–b13–b14 sheets may
be caused by an incomplete collapse of the empty drug-
binding pocket relative to the other HIV-1 RT structures
not containing NNRTIs.
Calculation of the solvent-accessible surface area based on
a 1.6 Å probe for the current unliganded HIV-1 RT struc-
ture reveals two surface depressions at the base of the
NNRTI-binding pocket that are plausible candidates for
the entrance to the pocket (Fig. 2). These two surface
depressions were also observed in the RT–DNA–Fab
complex. One surface depression is located at the proposed
entrance near Lys101, Lys103, Val179 (p66), and Glu138
(p51) (site 1) [9]. The other one is near the base of the
thumb subdomain between two adjacent polypeptide seg-
ments: the b5–b6 connecting loop (containing Lys101 and
Lys103) and the b13–b14 hairpin (containing Pro236 and
Lys238) (site 2). Both sites are exposed to solvent. It is pos-
sible that an NNRTI can approach the binding pocket via
either site and displace the Tyr181 and Tyr188 side chains.
Once the NNRTI is bound, however, only the putative
entrance near site 1 remains accessible [9]. Site 2 disap-
pears in the NNRTI-bound HIV-1 RT structure as a result
of a hinge-like movement of the b12–b13–b14 sheet rela-
tive to the b6–b10–b9 sheet. The exact inhibitor entrance
and the mechanism(s) of entry are still unclear.
Conformational distortions induced by NNRTI binding
As noted by Rodgers et al., the displacement of the p66
thumb subdomain is the most dramatic change between
the structures of the unliganded RT, the RT–DNA–Fab
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complex, and the RT–NNRTI complexes. The structures
of RT in this unliganded form and in the DNA-bound form
superimposed quite well with an rms deviation of 1.3 Å
based on all the Ca atoms, excluding the p66 thumb subdo-
main. Superposition of the structure of the RT–DNA–Fab
complex and the unliganded form of HIV-1 RT, based on
the Ca atoms of the b6–b10–b9 sheet, reveals that the 
p66 thumb subdomain, in the RT–DNA–Fab complex, is
rotated 30° away from the p66 fingers and the polymerase
active site (Fig. 3a), similar to that noted by Rodgers et al.
This rotation functions like a thumb’s knuckle and the axis
of the rotation is located at the base of thumb (around
residue Trp239 and Val317). The other subdomains of the
polymerase domain and the RNase H domain in p66
remain in similar positions in the unliganded RT and the
RT–DNA–Fab complex.
The structures of the unliganded RT and the NNRTI-
bound RT agree quite nicely within individual subdo-
mains (rms deviations are within 1.5 Å, based on the Ca
atoms in each subdomain). However, superposition of the
whole molecules does not show as good agreement (rms
deviation of 2.1 Å). If the structures are superimposed
based on the Ca atoms of the b6–b10–b9 sheet, binding
an NNRTI causes a hinge-like movement between the
b6–b10–b9 sheet and the b12–b13–b14 sheet. The
hinging is near, but not coincident with the axis of the
thumb’s knuckle motion (Fig. 3b). This hinge-like move-
ment, which is similar to the internal swivel motion sug-
gested by Jäger et al. [15], extends the position of the p66
thumb subdomain beyond the upright position seen in the
RT–DNA complex. In the inhibitor-bound HIV-1 RT
structures, the p66 thumb subdomain is rotated approxi-
mately 40° relative to the p66 fingers subdomain com-
pared with its position in the unliganded RT. This
rotation is significantly larger than the corresponding 30°
rotation in the RT–DNA–Fab complex. Comparing the
unliganded RT and the DNA-bound RT shows that the
hinge movement is coupled with the binding of NNRTIs.
Associated with the hinge movement of the p66 thumb,
the p66 connection and RNase H subdomains move away
relative to the fingers subdomain with 13° and 15° rota-
tions, respectively, compared with the corresponding posi-
tions in the unliganded RT (Fig. 3b). The position of the
p66 fingers subdomain in the HIV-1 RT–NNRTI com-
plexes is relatively unchanged (less than 4° rotation when
compared with the unliganded RT). The subdomains in
the p51 subunit of the NNRTI-bound RT also move (10°,
12°, 15°, and 17° for fingers, palm, thumb, and connection
subdomains, respectively). As a result, the intersubunit
interactions at the heterodimer interfaces are maintained
in both the unliganded RT and the RT–NNRTI complex,
suggesting that the heterodimer interface is relatively
stable. It is interesting to note that the binding of a rela-
tively small inhibitor molecule is accompanied by such
dramatic rearrangements of the subdomains.
Mechanistic implications for the inhibition by NNRTIs
Comparison of the available structures of HIV-1 RT indi-
cates that the binding of an NNRTI causes both short-
range and long-range distortions of the HIV-1 RT structure.
The short-range distortions include conformational changes
of the amino acid residues and/or structural elements that
form the NNIBP, such as reorientation of the side chains of
Tyr181 and Tyr188, and displacement of the b12–b13–b14
sheet. These distortions affect the precise geometry of the
polymerase active site. The long-range distortions involve a
hinging movement of the p66 thumb subdomain that
results in the displacement of the p66 connection subdo-
main, the RNase H domain, and the p51 subunit relative to
the polymerase active site. The observation that the chemi-
cal step of DNA polymerization is slowed by NNRTI
binding [16,17] may be explained by the short-range struc-
tural distortions induced by NNRTI binding, including the
conformational changes of the primer grip. Both short-range
and long-range structural distortions induced by NNRTI
binding alter the interactions between the nucleic acid sub-
strates and HIV-1 RT, and affect the precise positioning of
the template-primer relative to the polymerase and the
RNase H active sites. NNRTI-induced changes in RT
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Figure 2
Stereoview of the solvent-accessible surface
of the p66 palm subdomain in the unliganded
RT structure showing the two surface
depressions (indicated by arrows) near the
NNIBP that are potential entrances to the
inhibitor-binding pocket. One (site 1) is
located at the proposed entrance near
residues Lys101, Lys103, Val179 (p66) and
Glu138 (p51). The other (site 2) is between
Lys101/Lys103 and Pro236/Lys238, that is,
at the base of the p66 thumb subdomain. The
latter one disappears after binding of an
NNRTI. Water molecules (cyan) are seen in
both surface depressions.
interactions with nucleic acid substrates may partly account
for the observations that NNRTI binding can alter the
affinity of HIV-1 RT for the template-primer [16,18] as
well as the specificity of RNase H cleavage [19]. HIV-1 RT
mutations near the polymerase active site that had a greater
effect on RNase H activity than on polymerase activity
[20–22] have been described, supporting the idea that com-
munication between distant sites on HIV-1 RT (e.g., the
polymerase and RNase H active sites, the NNIBP, and
other sites that interact with template-primer) can occur via
the template-primer [8,11,22,23]. It is difficult to be certain,
however, that repositioning of the template-primer would
be solely responsible for the effect of NNRTI binding on
RNase H cleavage specificity, as binding does cause other
long-range movements of subdomains of both p51 and p66
relative to each other. The long-range distortions caused by
NNRTIs have the potential to affect other RT activities
such as strand transfer, strand displacement, and recogni-
tion of the tRNA used for priming reverse transcription.
Biological implications
The cumulative biological, genetic, and structural infor-
mation about HIV-1 reverse transcriptase (RT) has con-
siderably enhanced our understanding of the mechanisms
of polymerization and inhibition. However, the struc-
tures of unliganded HIV-1 RT previously reported differ
significantly in the conformation of the polymerase
domain of the p66 subunit. This has led to controversy
concerning the involvement of the p66 thumb subdo-
main in the mechanism of DNA polymerization and the
mechanism of inhibition by non-nucleoside inhibitors
(NNRTIs).
We report here the crystal structure of an unliganded
HIV-1 RT crystallized in space group C2, with molecu-
lar packing similar to that of the NNRTI-bound HIV-1
RT complexes. The overall folding of this enzyme is
similar to that determined by Rodgers et al. [12]. In these
two structures, the p66 thumb subdomain is folded into
the DNA-binding cleft. The differences observed among
the unliganded HIV-1 RTs in different crystal forms
demonstrates the considerable flexibility of the p66 thumb
subdomain, which may play an important role in the
recognition of nucleic acid substrates and the transloca-
tion of the enzyme along the nucleic acid after incorpora-
tion of each new nucleotide. It is likely that the flexibility
of the p66 thumb allows it to facilitate the repositioning
(and ‘reloading’) of RT during polymerization.
A comparison of the structures of the NNRTI-bound RT
complexes with those of unliganded RT and the HIV-1
RT–DNA–Fab complex [11] shows that the binding of
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Figure 3
Superposition of (a) unliganded RT and
RT–DNA–Fab complex and (b) unliganded
RT and RT–a-APA (a-anilinophenylacetamide)
complex based on 89 Ca atoms in the p66
palm subdomain, including the b6–b10–b9
region. The unliganded RT is shown in red,
RT–a-APA in blue, and RT–DNA–Fab in
green. A comparison of the two
superpositions reveals that NNRTI binding
appears to be accompanied by a long-range
distortion that is coupled with a hinge motion
(indicated by curved arrows) between the
b6–b10–b9 and b12–b13–b14 sheets at
the p66 palm subdomain (within the circle).
The different positions of the thumb in
different HIV-1 RT structures supports the
idea that this subdomain could play a role
during polymerization. 
an NNRTI causes both short-range and long-range
structural distortions. A hinge movement at the base of
the p66 thumb subdomain (near the ‘thumb’s knuckle’)
appears to constrain the thumb in a wide-open configura-
tion in the HIV-1 RT–NNRTI complexes, which is
extended beyond the upright configuration seen in the
HIV-1 RT–DNA–Fab structure. Biochemical and struc-
tural data suggest that the conformational changes
accompanying NNRTI binding alter the positioning of
the template-primer relative to the polymerase and
RNase H active sites. This could potentially account both
for the inhibition of RT activity (short-range effects) and
the alteration of RNase H cleavage specificity (long-
range effects) by NNRTIs.
Materials and methods
Crystallization and data collection
The unliganded HIV-1 RT was crystallized ([24] and references therein)
using modified conditions reported by Kohlstaedt et al. for crystallizing
the HIV-1 RT/nevirapine complex [5]. The initial crystals were grown in
the absence of NNRTIs by streak-seeding with crushed RT/a-APA
crystals. After crystals of unliganded HIV-1 RT were obtained, they
were used for further seeding. Crystals grew to an average size of
0.1 mm × 0.2 mm × 0.4 mm after two weeks and had the symmetry of
space group C2, which is the same as that of the HIV-1 RT–NNRTI
complexes. The cooled diffraction data were collected at the F1 beam
line (l = 0.91 Å) of the Cornell High Energy Synchrotron Source
(CHESS) from seven crystals cooled to –10°C. Data were recorded on
Fuji imaging plates with an overall Rmerge of 11.8% and a completeness
of 76.6% to 3.3 Å resolution. Another diffraction dataset was collected
at the CHESS F1 beam line from a single crystal at –165°C using the
flash-cooled technique [25,26]. This dataset, which was used for struc-
tural determination and refinement, has an overall Rmerge of 5.5%, a
completeness of 99.5% to 2.7 Å resolution (no s cutoff was used, and
the average measurement redundancy was 3.5). The HKL package
[27,28] was initially used to process, reduce, scale, and postrefine 
the data. Final data were scaled using SCALA (CCP4) [29]. A TAMM
derivative diffraction dataset was collected at the CHESS A1 beam line
and was scaled to the native dataset using FHSCAL of CCP4. The
statistics of all diffraction data are summarized in Table 1.
Structure determination and refinement
The structure of the unliganded HIV-1 RT was determined with the
molecular replacement (MR) technique as implemented in X-PLOR
[30], using the diffraction data from the frozen crystal and the coordi-
nates of the unliganded RT provided by Rodgers et al. as the starting
model [12]. The rotation function search and translation function
search yielded one distinct solution. The correctness of the MR solu-
tion was confirmed by the positions of mercury atoms in a difference
Fourier map computed between the TAMM derivative dataset and the
native dataset phased with the initial MR model. A subset of 6% of the
frozen dataset was separated for calculating the free R-factor to
monitor the progress of refinement. No subset of data was generated
for the free R-factor calculation for the cooled diffraction dataset due
to the relative incompleteness of the dataset. Iterative refinement and
model building were performed using the programs X-PLOR [30] and
O [31]. Omit maps were calculated for both the frozen and the cooled
datasets and then averaged between the frozen and cooled datasets
to improve the map quality and reduce model bias (KD et al. unpub-
lished data). The final refinement converged to an R-factor of 24.9%
and a free R-factor of 33.6% for the frozen crystal dataset, and an R-
factor of 23.0% for the cooled dataset. The fit of the atomic model into
the final 2mFobs–Fcalc electron density map in the region of the p66
connection subdomain is shown in Figure 4. A total of 267 water
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Table 1
Summary of crystallographic data and refinement statistics.
Datasets Native (cooled) Native (frozen) TAMM (frozen)
Diffraction data statistics
No. of crystals 7 1 1
No. of images 79 112 92
Temperature (°C) –10 –165 –165
a,b,c (Å) 240.3,71.5,95.5 235.5,70.3,93.3 234.0,69.7,93.0
b (°) 104.4 106.1 106.2
Resolution (Å) 3.3 2.7 3.7
Observed reflections (%) 24 727 142 770 46 901
Unique reflections (%) 18 345 41 049 15 521
Completeness (%) 76.6 99.5 99.4
Rmerge* (%) 11.8 5.5 11.2
Rderiv† (%) 21.8
Refinement statistics
Resolution range (Å) 8.0–2.7
No. of reflections‡ 38 310
R factor# (%) 24.9%
Free R factor (%) 33.6%
No. of protein atoms 7692
No. of water molecules 267
Average B factor (Å2) 44
Rms deviations
Bond (Å) 0.01
Angles (°) 2.0
*Rmerge =S|Iobs–<I>|/S<I>.†Rderiv =S|IPH–IP|/SIP. ‡No. of reflections used in refinement have F≥2s(F). #R=S||Fobs|–|Fcalc||/S|Fobs|.
molecules were found that have good stereochemistry. Some residues
are apparently disordered and have very weak electron density. These
residues have been modeled as alanines, including residues 22, 28,
64, 70–71, 134–136, 139, 169, 177, 194, 203, 218, 224, 242, 278,
281, 291, 297, 305, 311–312, 334, 336, 356–359, 404, 407,
413–414, 424, 448, 451, 512, 514, 527, 549–551, and 556 in the
p66 subunit, and residues 36, 67–69, 88–89, 173, 197, 238,
281–282, 295, 297, 305–306, 308, 356–358, 361–362, 407,
424–425, and 427 in the p51 subunit. A part of the connecting loop
between aF and b13 in the p51 subunit (residues 219-231) has weak
electron density and thus has not been modeled. Final refinement
statistics are listed in Table 1. 
Accession numbers
Coordinates for the final model of the native structure refined using the
frozen dataset have been deposited with the Brookhaven Protein Data
Bank (entry code1DLO).
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